Alnylam Pharmaceuticals | ALNY - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Arrowhead Research USD 8.78B 236M 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
PTC Therapeutics USD 5.64B 460M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Takeda JPY 9.01T 1.37T 2026-03
Tectonic Therapeutic USD 390M 96M 2025-12
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Xencor USD 893M 200M 2026-03